Philip McCoy

488 total citations
11 papers, 383 citations indexed

About

Philip McCoy is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Philip McCoy has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Philip McCoy's work include Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers) and RNA modifications and cancer (1 paper). Philip McCoy is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers) and RNA modifications and cancer (1 paper). Philip McCoy collaborates with scholars based in United States and China. Philip McCoy's co-authors include Leigh Samsel, Abdul Tawab, Yong Fan, Richard Childs, Andreas Lundqvist, Maria Berg, Zhi‐Ming Zheng, Rong Jia, Lulu Yu and Masahiko Ajiro and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Philip McCoy

11 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip McCoy United States 5 260 194 93 82 31 11 383
Tina Nuebling Germany 9 270 1.0× 247 1.3× 132 1.4× 106 1.3× 18 0.6× 13 455
Anni Skovbo Denmark 9 247 0.9× 172 0.9× 110 1.2× 119 1.5× 25 0.8× 13 403
Jessica Cantrell United States 8 291 1.1× 160 0.8× 78 0.8× 57 0.7× 17 0.5× 10 396
Manfred Smetak Germany 9 465 1.8× 357 1.8× 56 0.6× 62 0.8× 63 2.0× 17 573
Shihong Yang Australia 10 254 1.0× 180 0.9× 105 1.1× 220 2.7× 27 0.9× 21 403
Eva Gaarsdal Denmark 13 280 1.1× 252 1.3× 126 1.4× 220 2.7× 30 1.0× 19 514
Zhihua Tian China 5 280 1.1× 107 0.6× 40 0.4× 169 2.1× 54 1.7× 8 404
Yu Abe Japan 9 186 0.7× 169 0.9× 102 1.1× 99 1.2× 9 0.3× 27 326
F Triebel France 8 369 1.4× 197 1.0× 54 0.6× 34 0.4× 21 0.7× 11 435
Magdalena Hinterbrandner Switzerland 6 117 0.5× 145 0.7× 105 1.1× 101 1.2× 15 0.5× 7 270

Countries citing papers authored by Philip McCoy

Since Specialization
Citations

This map shows the geographic impact of Philip McCoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip McCoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip McCoy more than expected).

Fields of papers citing papers by Philip McCoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip McCoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip McCoy. The network helps show where Philip McCoy may publish in the future.

Co-authorship network of co-authors of Philip McCoy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip McCoy. A scholar is included among the top collaborators of Philip McCoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip McCoy. Philip McCoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Jia, Rong, Masahiko Ajiro, Lulu Yu, Philip McCoy, & Zhi‐Ming Zheng. (2019). Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation. RNA. 25(5). 630–644. 48 indexed citations
2.
Lawner, Benjamin J., et al.. (2019). Challenges Related to the Implementation of an EMS-Administered, Large Vessel Occlusion Stroke Score. Western Journal of Emergency Medicine. 21(2). 441–448. 7 indexed citations
3.
Aue, Georg, Jay N. Lozier, Xin Tian, et al.. (2011). Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. American Journal of Hematology. 86(10). 835–840. 31 indexed citations
4.
5.
Berg, Maria, Andreas Lundqvist, Philip McCoy, et al.. (2009). Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy. 11(3). 341–355. 235 indexed citations
6.
7.
Vire, Bérengère, Elinor Lee, Lawrence Stennett, et al.. (2009). Loss of CD20 Expression and Exhaustion of Effector Cells Limit ADCC in CLL Patients Treated with Rituximab.. Blood. 114(22). 1610–1610. 2 indexed citations
8.
Rao, Sheila, Abdul Tawab, Roger Kurlander, et al.. (2008). The human endogenous retrovirus (HERV) derived kidney Cancer antigen CT-RCC1 induces proliferation of CD8+ antigen-specific T-cells in vitro that kill renal cell carcinoma (RCC) and is up-regulated by inhibiting histone deacetylase. Cancer Research. 68. 1033–1033. 2 indexed citations
9.
Lundqvist, Andreas, John Andersson, Mohamed F. Elshal, et al.. (2005). Allograft Cell Content and GVHD Differ in Murine Recipients of AMD3100 Versus G-CSF Mobilized Peripheral Blood Stem Cells.. Blood. 106(11). 3108–3108. 1 indexed citations
10.
Powell, Tiffany M, Jonathan Paul, Jonathan Hill, et al.. (2004). 1045-193 Granulocyte-colony stimulating factor mobilizes and activates endothelial progenitor cells in patients with coronary artery disease. Journal of the American College of Cardiology. 43(5). A458–A458. 2 indexed citations
11.
Charley, Michael R., Michael D. Tharp, Joseph Locker, et al.. (1990). Establishment of a Human Cutaneous T-Cell Lymphoma in C.B-17 SCID Mice. Journal of Investigative Dermatology. 94(3). 381–384. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026